Skip to main content
. 2015 Apr 21;10(4):e0123638. doi: 10.1371/journal.pone.0123638

Fig 4. Comparison of allograft, patient survival rate and the change of allograft function.

Fig 4

No difference was detected among four groups in (A) allograft survival rate, (B) patient survival rate and the (C) change of allograft function up-til 1 year from transplantation. ABOi, ABO incompatible; HLAs, highly sensitization to HLA; CONT, control group; MDRD; modification of diet in renal disease; eGFR, estimated glomerular filtration disease. * P<0.05 vs. ABOi, † P<0.05 vs. ABOi+HLAs, ‡ P<0.05 vs. HLAs, § P<0.05 vs. CONT.